These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8380056)
1. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Lu QL; Elia G; Lucas S; Thomas JA Int J Cancer; 1993 Jan; 53(1):29-35. PubMed ID: 8380056 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival. Vera-Sempere FJ; Burgos JS; Botella MS; Morera C Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038 [TBL] [Abstract][Full Text] [Related]
3. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Murono S; Yoshizaki T; Park CS; Furukawa M Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418 [TBL] [Abstract][Full Text] [Related]
4. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas]. Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067 [TBL] [Abstract][Full Text] [Related]
5. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression. Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459 [TBL] [Abstract][Full Text] [Related]
6. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Niemhom S; Kitazawa S; Murao S; Kunachak S; Maeda S Cancer Lett; 2000 Nov; 160(2):199-208. PubMed ID: 11053650 [TBL] [Abstract][Full Text] [Related]
7. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction. Murono S; Yoshizaki T; Tanaka S; Takeshita H; Park CS; Furukawa M Laryngoscope; 1997 Apr; 107(4):523-6. PubMed ID: 9111384 [TBL] [Abstract][Full Text] [Related]
8. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Brousset P; Butet V; Chittal S; Selves J; Delsol G Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609 [TBL] [Abstract][Full Text] [Related]
9. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis. Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525 [TBL] [Abstract][Full Text] [Related]
11. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2. Guo L; Guo Y; Xiao S Cancer Lett; 2006 Feb; 232(2):255-61. PubMed ID: 16458122 [TBL] [Abstract][Full Text] [Related]
12. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma. Chen CL; Hsu MM; Hsu HC Intervirology; 1996; 39(4):230-5. PubMed ID: 9078463 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma. Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H Med Microbiol Immunol; 2003 Aug; 192(3):141-4. PubMed ID: 12920589 [TBL] [Abstract][Full Text] [Related]
16. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Burgos JS Med Oncol; 2005; 22(2):113-21. PubMed ID: 15965273 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease? Khan G; Gupta RK; Coates PJ; Slavin G Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok. Niemhom S; Maeda S; Raksakait K; Petchclai B Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977 [TBL] [Abstract][Full Text] [Related]